- Filed
- Mar 18, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Mar 8, 2024 | 153.11M sh |
| Cash And Equivalents | Q2 2024 · Jan 31, 2024 | $4.83K |
| Cash And Equivalents | Q2 2024 · Jul 31, 2023 | $1.3K |
| Current Liabilities | Q2 2024 · Jan 31, 2024 | $36.65K |
| Current Liabilities | Q2 2024 · Jul 31, 2023 | $6.7K |
| Total Liabilities | Q2 2024 · Jan 31, 2024 | $36.65K |
| Total Liabilities | Q2 2024 · Jul 31, 2023 | $6.7K |
| Current Assets | Q2 2024 · Jan 31, 2024 | $5.01K |
| Current Assets | Q2 2024 · Jul 31, 2023 | $1.3K |
| Total Assets | Q2 2024 · Jan 31, 2024 | $5.01K |
| Total Assets | Q2 2024 · Jul 31, 2023 | $1.3K |
| Eps Diluted | Q2 2024 · Jan 31, 2024 | $0.00 |
| Eps Diluted | Q2 2024 · Jan 31, 2024 | $0.00 |
| Eps Basic | Q2 2024 · Jan 31, 2024 | $0.00 |
| Eps Basic | Q2 2024 · Jan 31, 2024 | $0.00 |
| Rd Expense | Q2 2024 · Jan 31, 2024 | $0 |
| Rd Expense | Q2 2024 · Jan 31, 2023 | $41.53K |
| Shares Diluted | Q2 2024 · Jan 31, 2023 | 153.11M sh |
| Shares Diluted | Q2 2024 · Jan 31, 2023 | 153.11M sh |
| Stockholders Equity | Q2 2024 · Jan 31, 2023 | −$665.26K |
| Stockholders Equity | Q2 2024 · Oct 31, 2022 | −$568.23K |
| Stockholders Equity | Q2 2024 · Jul 31, 2022 | −$498.16K |
| Net Income | Q2 2024 · Jan 31, 2023 | −$69.85K |
| Net Income | Q2 2024 · Jan 31, 2023 | −$163.07K |
| Operating Income restated | Q2 2024 · Jan 31, 2023 | −$3.12K |
| Operating Income restated | Q2 2024 · Jan 31, 2023 | −$30.02K |